Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 4/2018

01-04-2018 | Image of the Month

FDG PET-CT as a powerful tool for diagnosing and monitoring treatment outcomes of relapsing polychondritis

Authors: Pauline Baudart, Achille Aouba, Marie Beaufrère, Nicolas Aide

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2018

Login to get access

Excerpt

Relapsing polychondritis (RP) is a rare connective tissue disease characterized by recurrent inflammation of cartilaginous tissues [1]. Diagnoses are often delayed until destruction of the nose, laryngeal, or ear structures has occurred. Here, we report on the use of FDG PET for the diagnosis and therapeutic monitoring of RP [2, 3]. …
Literature
1.
Longo L, Greco A, Rea A, Lo Vasco VR, De Virgilio A, De Vincentiis M. Relapsing polychondritis: a clinical update. Autoimmun Rev. 2016;15(6):539–43.CrossRefPubMed
2.
De Geeter F. Nuclear imaging in relapsing polychondritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2013;19(2):55–6.
3.
4.
Michet CJ Jr, McKenna CH, Luthra HS, O’Fallon WM. Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104(1):74–8.CrossRefPubMed
Metadata
Title
FDG PET-CT as a powerful tool for diagnosing and monitoring treatment outcomes of relapsing polychondritis
Authors
Pauline Baudart
Achille Aouba
Marie Beaufrère
Nicolas Aide
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-017-3906-y

Other articles of this Issue 4/2018

European Journal of Nuclear Medicine and Molecular Imaging 4/2018 Go to the issue

Original Article

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques

Original Article

Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR

Correction

Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma

Original Article

Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy

Original Article

Impact of initial myocardial perfusion imaging versus invasive coronary angiography on outcomes in coronary artery disease: a nationwide cohort study

Original Article

Prediction of functional recovery after primary PCI using the estimate of myocardial salvage in gated SPECT early after acute myocardial infarction